Centro de Estudios Farmacológicos y Botánicos, CEFYBO-CONICET-UBA, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
J Neuroimmunol. 2010 Apr 15;221(1-2):32-41. doi: 10.1016/j.jneuroim.2010.02.006. Epub 2010 Mar 5.
This study investigated the participation of the hypothalamic endocannabinoid system in the response to lipopolysaccharide (LPS) challenge evaluating oxytocin (OXT) and tumor necrosis factor-alpha (TNF-alpha) plasma levels in vivo and their release from hypothalamic fragments in vitro. LPS increased OXT and TNF-alpha release through anandamide-activation of hypothalamic cannabinoid receptor CB(1,) since the antagonist AM251 blocked this effect. Anandamide, through its receptors, also increased hypothalamic nitric oxide (NO) which inhibited OXT release, ending the stimulatory effect of the endocannabinoid. Our findings reveal a hypothalamic interaction between oxytocin, endocannabinoid and NO-ergic systems providing a regulation of the hypothalamic-neurohypophyseal axis under basal and stress conditions.
本研究通过评估体内的催产素(OXT)和肿瘤坏死因子-α(TNF-α)的血浆水平以及体外下丘脑片段的释放,探讨了下丘脑内源性大麻素系统在应对脂多糖(LPS)挑战中的作用。LPS 通过下丘脑大麻素受体 CB1 的激动剂大麻素激动剂 AM251 阻断了这一效应,增加了 OXT 和 TNF-α 的释放。内源性大麻素通过其受体也增加了下丘脑一氧化氮(NO)的释放,从而抑制了 OXT 的释放,结束了内源性大麻素的刺激作用。我们的研究结果揭示了在下丘脑水平上催产素、内源性大麻素和 NO 能系统之间的相互作用,为在基础和应激条件下调节下丘脑-神经垂体轴提供了依据。